MedPath

Testing Adapted Self-Help Plus (SH+) for Stress and Well-Being in International Students at a U.S. University

Not Applicable
Recruiting
Conditions
Stress, Psychological
Depression and/or Anxiety in the Mild-to-moderate Range
Loneliness
Adjustment, Psychological
Registration Number
NCT07188467
Lead Sponsor
The New School
Brief Summary

The goal of this clinical trial is to learn if an adapted version of Self-Help Plus (SH+), a stress management program developed by the World Health Organization, can reduce stress and improve well-being in international students at a U.S. university. The main questions it aims to answer are:

Does SH+ reduce perceived stress, anxiety, and depressive symptoms in international students? Does SH+ improve feelings of social support, self-efficacy, and adjustment in a new cultural environment?

Participants will:

Attend a two-day in-person workshop that includes animated videos, interactive activities, and group discussions.

Complete three surveys (before the workshop, right after, and six weeks later) about stress, mood, and well-being.

Optionally, take part in a short interview to share feedback about their experience.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Enrolled as an international student at The New School
  • Age 18 years or older
  • Willing to provide informed consent and complete study assessments
  • Score of ≥3 on the PHQ-4, indicating at least mild distress
  • Sufficient English proficiency to comprehend intervention materials
Exclusion Criteria
  • Severe psychiatric conditions requiring immediate intervention (e.g., active psychosis, severe mood disorders)
  • Visual, hearing, or neurocognitive impairments that prevent engagement with the intervention
  • Having an advanced degree in psychology or mental health-related fields (to prevent prior knowledge bias)
  • Score of 2 or higher on PHQ-4 Item 3 or Item 4 (frequent thoughts of self-harm or severe distress)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Perceived Stress Scale (PSS-10)Change from baseline to 6-week follow-up

Self-reported perceived stress levels. Higher scores indicate greater perceived stress.

Range: 0-40 Higher scores= worse outcome (greater perceived stress) Cutoffs: 0-13 low, 14-26 moderate, 27-40 high

Patient Health Questionnaire (PHQ-9)Change from baseline to 6-week follow-up

Range: 0-27 Higher scores = worse outcome (greater depression severity). Cutoffs: 1-4 minimal, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.

General Anxiety Disorder (GAD-7)Change from baseline to 6-week follow-up

Range: 0-21 Higher scores = worse outcome (greater anxiety severity) Cutoffs: 0-4 minimal, 5-9 mild, 10-14 moderate, 15-21 severe

Secondary Outcome Measures
NameTimeMethod
Social Support (SSQ)Change from baseline to 6-week follow-up

Range varies (depends on individual): self-reported number of people available for support + satisfaction rating).

Higher scores = better outcome (greater perceived support and satisfaction).

Psychological Adjustment (BASE-6)Change from baseline to 6-week follow-up

Range: 6-42 (six items, each scored 1-7). Higher scores = worse outcome (greater emotional distress and adjustment difficulty).

Self-Measure for Loneliness (UCLA Loneliness Scale)Change from baseline to 6-week follow-up

Range: 0-60 (20 items, scored 0-3) Higher scores = worse outcome (greater loneliness/social isolation).

Self-Efficacy (General Self-Efficacy Scale)Change from baseline to 6-week follow-up

Range: 10-40 (10 items, scored 1-4). Higher scores = better outcome (greater self-efficacy/confidence in coping).

Trial Locations

Locations (1)

The New School

🇺🇸

Brooklyn, New York, United States

The New School
🇺🇸Brooklyn, New York, United States
Josheka Chauhan
Contact
3473072179
chauj265@newschool.edu
Adam D. Brown, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.